EZH2 and cancer: This includes the demonstration of a novel regulatory mechanism for arguably two of the most important genes in FL, BCL2 and EZH2. This work suggests that noncoding mutations and specifically mutations in miRNA-binding sites, although often over-looked in genetic studies, are likely to be important factors in lymphomagenesis and cancer in general that surely warrant further investigation.